Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,986 public trials 1,832 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Recruiting

TSN222 in Subjects With Advanced Solid Tumors or Lymphomas

NCT05842785

Conditions: Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Fudan Cancer Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab

NCT04014374

Conditions: ATLL, Cutaneous T Cell Lymphoma, Hematologic Diseases, +16 more
Locations: CIBMTR Milwaukee, Wisconsin, United States

View Trial Details

Recruiting

An Open-label, Single-arm Study of JWCAR201 in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma

NCT06517004

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Fudan University Shanghai Cancer Center Shanghai, China

View Trial Details

Recruiting

Biochemical Role of Circulating microRNAs Expression as Diagnostic Markers for Non-Hodgkin's Lymphoma Patients

NCT05921812

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Sohag University Sohag, Egypt

View Trial Details

Recruiting

Combination of Orelabrutinib and Obinutuzumab in Untreated Marginal Zone Lymphomas

NCT06513234

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: China Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences Tianjin, China

View Trial Details

Recruiting

Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL

NCT06287398

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, DLBCL, Nos Genetic Subtypes, Dendritic Cell Sarcoma, Interdigitating, +21 more
Locations: Australasian Leukemia and Lymphoma Group Melbourne, Victoria, Australia

View Trial Details

Recruiting

Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study Analysis

NCT06058858

Conditions: Acute Leukemia, B Cell Lymphoma, Cytomegalovirus Infections, +14 more
Locations: Hopital Robert Debré - APHP Paris, France

Hopital Saint Louis - APHP - Service d'hématologie " Unité Adolescents et jeunes adultes " Paris, France

Hopital Saint-Louis - APHP - Service d'éhamotologie - oncologie Paris, France

View Trial Details

Recruiting

Biomarkers for Diagnostic, Prognostic and of Response to Treatment in Adult Langerhans Cell Histiocytosis

NCT06197204

Conditions: Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +4 more
Locations: Hopital Saint Louis Paris, France

View Trial Details

Recruiting

On the Safety, Tolerability, and Efficacy of UTAA09 Injection in the Treatment of Lymphoma

NCT06503211

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: PersonGen.Anke Cellular Therapeutice Co., Ltd. Hefei, Anhui, China

View Trial Details

Recruiting

CD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological Tumors

NCT06503094

Conditions: B-Cell Lymphoblastic Leukemia/Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions